Turbidimetric Inhibition Immunoassay Revisited to Enhance Its Sensitivity Via an Optofluidic Laser.

Xi Yang,Wenxiong Shu,Yanqiong Wang,Yuan Gong,Chaoyang Gong,Qiushu Chen,Xiaotian Tan,Gang-Ding Peng,Xudong Fan,Yun-Jiang Rao
DOI: https://doi.org/10.1016/j.bios.2019.02.013
IF: 12.545
2019-01-01
Biosensors and Bioelectronics
Abstract:Turbidimetric inhibition immunoassay (TIIA) is a classic immunodiagnostic method that has been extensively used for biomarker detection. However, the low sensitivity of this technique hinders its applications in the early diagnosis of diseases. Here, a new concept, optofluidic laser TIIA (OFL-TIIA), is proposed and demonstrated for sensitive protein detection. In contrast to the immunoreaction in traditional TIIA, in which the single-pass laser loss is detected, the immunoreaction in the OFL-TIIA method takes place in a laser cavity, which considerably increases the loss induced by antigen-antibody complexes (AACs) via the amplification effect of the laser. A commercial IgG TIIA kit was selected as a demonstrative model to characterize the performance of OFL-TIIA. A wide dynamic range of five orders of magnitude with an exceptional limit of detection (LOD) (1.8 x 10(-10) g/L) was achieved. OFL-TIIA is a fast, sensitive, and low-cost immunoassay with a simple homogeneous and wash-free process and low-volume sample consumption, thus providing a new detection platform for disease diagnostics.
What problem does this paper attempt to address?